Related Experiment Video
Updated: Aug 5, 2026
08:48
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Integrated platform for accelerating therapeutic macrocyclic peptide purification in high-throughput medicinal
Jun Wang1, Faben Cruz1, Lingfei Wang1
1Discovery Chemistry, Merck & Co., Inc. 213. E. Grand Ave. South San Francisco CA 94080 USA kanaka.hettiarachchi@merck.com +1 650 496 1161.
RSC Medicinal Chemistry
|July 28, 2026
Summary
This study presents a streamlined platform for peptide purification, enhancing drug discovery efficiency. It utilizes predictive chromatography and automated systems to reduce costs and accelerate the development of new peptide therapeutics.
Area of Science:
- Pharmaceutical Sciences
- Analytical Chemistry
- Medicinal Chemistry
Background:
- Peptides offer unique therapeutic advantages over small molecules in drug discovery.
- High-throughput peptide synthesis and purification workflows are essential for modern drug discovery programs.
- Traditional peptide purification methods present bottlenecks, necessitating innovative solutions.
Purpose of the Study:
- To demonstrate a streamlined, unified platform for the purification of synthetic macrocyclic peptides.
- To integrate digital tools and advanced instrumentation for efficient peptide purification.
- To reduce the overall operational cost and time in the drug design-make-test cycle.
Main Methods:
- Utilized a commercial software tool for chromatographic method prediction based on quantitative structure-retention relationships (QSRR).
- Employed a semi-preparative reversed-phase high-performance liquid chromatography (RP-HPLC) system.
- Incorporated a triple detector configuration with charged aerosol detection (CAD) for comprehensive impurity profiling and quantitation.
Main Results:
- The platform successfully purified macrocyclic peptides across a wide range of sample scales (0.25 to 25.0 μmol) without compromising resolution, purity, or recovery.
- Achieved direct quantitation of low-yielding samples using CAD.
- Demonstrated applicability to various modalities, including small molecules and bioconjugates.
Conclusions:
- The developed platform significantly streamlines synthetic macrocyclic peptide purification, from submission to reporting.
- This integrated approach reduces organic solvent consumption, toxic waste, and operational costs compared to legacy methods.
- The workflow accelerates the design-make-test cycle, facilitating faster development of peptide-based therapeutics.
